Contact

All Stories

  1. Larval T Cells Are Functionally Distinct from Adult T Cells in Xenopus laevis

    Article • ImmunoHorizons, October 2023, The American Association of Immunologists

    Dr Jacques Robert

  2. Introduction to the special issue Amphibian immunity: stress, disease and ecoimmunology

    Article • Philosophical Transactions of the Royal Society B Biological Sciences, June 2023, Royal Society Publishing

    Dr Jacques Robert

  3. The amphibian immune system

    Article • Philosophical Transactions of the Royal Society B Biological Sciences, June 2023, Royal Society Publishing

    Dr Jacques Robert

  4. Environmental endocrine disruptors and amphibian immunity: A bridge between the thyroid hormone axis and T cell development

    Article • Developmental & Comparative Immunology, March 2023, Elsevier

    Dr Jacques Robert

  5. Amphibians as a model to study the role of immune cell heterogeneity in host and mycobacterial interactions

    Article • Developmental & Comparative Immunology, February 2023, Elsevier

    Dr Jacques Robert

  6. Evolution and Potential Subfunctionalization of Duplicated fms-Related Class III Receptor Tyrosine Kinase flt3s and Their Ligands in the Allotetraploid Xenopus laevis

    Article • The Journal of Immunology, September 2022, The American Association of Immunologists

    Dr Jacques Robert

  7. γδ T, NKT, and MAIT Cells During Evolution: Redundancy or Specialized Functions?

    Article • The Journal of Immunology, July 2022, The American Association of Immunologists

    Dr Jacques Robert

  8. Virus-Targeted Transcriptomic Analyses Implicate Ranaviral Interaction with Host Interferon Response in Frog Virus 3-Infected Frog Tissues

    Article • Viruses, July 2021, MDPI AG

    Dr Jacques Robert

  9. TLR5-Mediated Reactivation of Quiescent Ranavirus FV3 in Xenopus Peritoneal Macrophages

    Article • Journal of Virology, May 2021, ASM Journals

    Dr Jacques Robert

  10. Virus-Targeted Transcriptomic Analyses Implicate Ranaviral Interaction with Host Interferon Response in Frog Virus 3-infected Frog Tissues

    Article • April 2021, Cold Spring Harbor Laboratory Press

    Dr Jacques Robert

  11. Thyroid Disrupting Chemicals in Mixture Perturb Thymocyte Differentiation in Xenopus laevis Tadpoles

    Article • Toxicological Sciences, March 2021, Oxford University Press (OUP)

    Dr Jacques Robert

  12. Developing Tadpole Xenopus laevis as a Comparative Animal Model to Study Mycobacterium abscessus Pathogenicity

    Article • International Journal of Molecular Sciences, January 2021, MDPI AG

    Dr Jacques Robert

  13. Immunological Aspects of Chytridiomycosis

    Article • Journal of Fungi, October 2020, MDPI AG

    Dr Jacques Robert

  14. Introduction

    Article • Immunological Investigations, August 2019, Taylor & Francis

    Dr Jacques Robert

  15. Evolutionary Underpinnings of Innate-Like T Cell Interactions with Cancer

    Article • Immunological Investigations, June 2019, Taylor & Francis

    Dr Jacques Robert

  16. Impacts of the MHC class I-like XNC10 and innate-like T cells on tumor tolerance and rejection in the amphibian Xenopus

    Article • Carcinogenesis, June 2019, Oxford University Press (OUP)

    Dr Jacques Robert

  17. Developmental exposure to chemicals associated with unconventional oil and gas extraction alters immune homeostasis and viral immunity of the amphibian Xenopus

    Article • The Science of The Total Environment, June 2019, Elsevier

    Dr Jacques Robert

  18. Critical Role of an MHC Class I-Like/Innate-Like T Cell Immune Surveillance System in Host Defense against Ranavirus (Frog Virus 3) Infection

    Article • Viruses, April 2019, MDPI AG

    Dr Jacques Robert

  19. Developmental Exposure to a Mixture of 23 Chemicals Associated With Unconventional Oil and Gas Operations Alters the Immune System of Mice

    Article • Toxicological Sciences, May 2018, Oxford University Press (OUP)

    Dr Jacques Robert

  20. Distinct MHC class I-like interacting invariant T cell lineage at the forefront of mycobacterial immunity uncovered in Xenopus

    Article • Proceedings of the National Academy of Sciences, April 2018, Proceedings of the National Academy of Sciences

    Dr Jacques Robert

  21. Frog's DCs have it all in one

    Article • European Journal of Immunology, March 2018, Wiley

    Dr Jacques Robert

  22. RNAi-Mediated Loss of Function of Xenopus Immune Genes by Transgenesis

    Article • Cold Spring Harbor Protocols, January 2018, Cold Spring Harbor Laboratory Press

    Dr Jacques Robert

  23. An Ancestral Immune Surveillance System in the Amphibian Xenopus Connecting Certain Heat Shock Proteins with Classical and Nonclassical MHC Class I Molecules

    Article • January 2018, Springer Science + Business Media

    Dr Jacques Robert

  24. First-in-man phase I study assessing the safety and pharmacokinetics of a 1-hour intravenous infusion of the doxorubicin prodrug DTS-201 every 3 weeks in patients with advanced or metastatic solid tumours

    Article • European Journal of Cancer, November 2017, Elsevier

    Dr Jacques Robert

  25. Xenopus-FV3 host-pathogen interactions and immune evasion

    Article • Virology, November 2017, Elsevier

    Dr Jacques Robert

  26. Collagen-Embedded Tumor Transplantations in Xenopus laevis Tadpoles

    Article • Cold Spring Harbor Protocols, September 2017, Cold Spring Harbor Laboratory Press

    Dr Jacques Robert

  27. Exploring the functions of nonclassical MHC class Ib genes in Xenopus laevis by the CRISPR/Cas9 system

    Article • Developmental Biology, June 2017, Elsevier

    Dr Jacques Robert

  28. Long term effects of carbaryl exposure on antiviral immune responses in Xenopus laevis

    Article • Chemosphere, March 2017, Elsevier

    Dr Jacques Robert

  29. Clinical impact of extensive molecular profiling in advanced cancer patients

    Article • Journal of Hematology & Oncology, February 2017, Springer Science + Business Media

    Dr Jacques Robert

  30. Evolutionary Aspects of Macrophages Polarization

    Article • January 2017, Springer Science + Business Media

    Dr Jacques Robert

  31. Evolutionary Perspective of Tumorigenesis and Antitumor Immunity: A Comparative Approach

    Article • January 2017, Elsevier

    Dr Jacques Robert

  32. Genome evolution in the allotetraploid frog Xenopus laevis

    Article • Nature, October 2016, Springer Science + Business Media

    Dr Kamran Karimi, Dr Jacques Robert

  33. Recombinant Ranaviruses for Studying Evolution of Host–Pathogen Interactions in Ectothermic Vertebrates

    Article • Viruses, July 2016, MDPI AG

    Dr Jacques Robert

  34. Evolution of innate-like T cells and their selection by MHC class I-like molecules

    Article • Immunogenetics, July 2016, Springer Science + Business Media

    Dr Jacques Robert

  35. Amphibian macrophage development and antiviral defenses

    Article • Developmental & Comparative Immunology, May 2016, Elsevier

    Dr Jacques Robert

  36. Preface to the special issue “Hematopoiesis and immunity”

    Article • Developmental & Comparative Immunology, May 2016, Elsevier

    Dr Jacques Robert

  37. Effect of Single Nucleotide Polymorphisms in the Xenobiotic-sensing Receptors NR1I2 and NR1I3 on the Pharmacokinetics and Toxicity of Irinotecan in Colorectal Cancer Patients

    Article • Clinical Pharmacokinetics, April 2016, Springer Science + Business Media

    Dr Jacques Robert

  38. Frog Virus 3 dissemination in the brain of tadpoles, but not in adult Xenopus, involves blood brain barrier dysfunction

    Article • Scientific Reports, March 2016, Springer Science + Business Media

    Dr Jacques Robert

  39. Ouro proteins are not essential to tail regression during Xenopus tropicalis metamorphosis

    Article • Genes to Cells, February 2016, Wiley

    Dr Jacques Robert

  40. A clinical case of invasive lobular breast carcinoma with ERBB2 and CDH1 mutations presenting a dramatic response to anti-HER2-directed therapy

    Article • Annals of Oncology, January 2016, Elsevier

    Dr Jacques Robert

  41. Xenopus tumor model

    Article • Developmental Biology, December 2015, Elsevier

    Dr Jacques Robert

  42. Xenopus in vivo imaging of inflammation

    Article • Developmental Biology, December 2015, Elsevier

    Dr Jacques Robert

  43. Characterization of Frog Virus 3 knockout mutants lacking putative virulence genes

    Article • Virology, November 2015, Elsevier

    Dr Jacques Robert

  44. Retention of duplicated ITAM-containing transmembrane signaling subunits in the tetraploid amphibian species Xenopus laevis

    Article • Developmental & Comparative Immunology, November 2015, Elsevier

    Dr Jacques Robert

  45. Nonclassical MHC-Restricted Invariant Vα6 T Cells Are Critical for Efficient Early Innate Antiviral Immunity in the Amphibian Xenopus laevis

    Article • The Journal of Immunology, July 2015, The American Association of Immunologists

    Dr Jacques Robert

  46. Distinct functional roles of amphibian (Xenopus laevis) colony-stimulating factor-1- and interleukin-34-derived macrophages

    Article • Journal of Leukocyte Biology, July 2015, Oxford University Press (OUP)

    Dr Jacques Robert

  47. Renouvellement des cellules souches et épidémiologie des cancers – À propos d’un article de Tomasetti et Vogelstein paru dans Science

    Article • Bulletin du Cancer, March 2015, Elsevier

    Dr Jacques Robert

  48. Xenopus laevis tadpoles anti-FV3 IFNλ response

    Article • Journal of Virology, February 2015, ASM Journals

    Dr Jacques Robert

  49. Ranavirus Host Immunity and Immune Evasion

    Article • January 2015, Springer Science + Business Media

    Dr Jacques Robert

  50. Inflammation-Mediated FV3 Reactivation

    Article • PLoS ONE, November 2014, PLOS

    Dr Jacques Robert

  51. Negative effects of low dose atrazine exposure on the development of effective immunity to FV3 in Xenopus laevis

    Article • Developmental & Comparative Immunology, November 2014, Elsevier

    Dr Jacques Robert

  52. On the use of pharmacogenetics in cancer treatment and clinical trials

    Article • European Journal of Cancer, October 2014, Elsevier

    Dr Jacques Robert

  53. Divergent antiviral roles of amphibian (Xenopus laevis) macrophages elicited by colony-stimulating factor-1 and interleukin-34

    Article • Journal of Leukocyte Biology, September 2014, Society for Leukocyte Biology

    Dr Jacques Robert

  54. Ciblage de mTOR et identification de «répondeurs exceptionnels»

    Article • Bulletin du Cancer, September 2014, Elsevier

    Dr Jacques Robert

  55. Evolution of nonclassical MHC-dependent invariant T cells

    Article • Cellular and Molecular Life Sciences, August 2014, Springer Science + Business Media

    Dr Jacques Robert

  56. Environmental dependency of amphibian–ranavirus genotypic interactions: evolutionary perspectives on infectious diseases

    Article • Evolutionary Applications, June 2014, Wiley

    Dr Jacques Robert

  57. A prominent role for invariant T cells in the amphibian Xenopus laevis tadpoles

    Article • Immunogenetics, June 2014, Springer Science + Business Media

    Dr Jacques Robert

  58. Differential transcription of fathead minnow immune-related genes following infection with frog virus 3, an emerging pathogen of ectothermic vertebrates

    Article • Virology, May 2014, Elsevier

    Dr Jacques Robert

  59. A critical role of non-classical MHC in tumor immune evasion in the amphibian Xenopus model

    Article • Carcinogenesis, April 2014, Oxford University Press (OUP)

    Dr Jacques Robert

  60. Unusual evolutionary conservation and further species-specific adaptations of a large family of nonclassical MHC class Ib genes across different degrees of genome ploidy in the amphibian subfamily Xenopodinae

    Article • Immunogenetics, April 2014, Springer Science + Business Media

    Dr Jacques Robert

  61. FOLFIRI® and Bevacizumab in first-line treatment for colorectal cancer patients: safety, efficacy and genetic polymorphisms

    Article • BMC Research Notes, April 2014, Springer Science + Business Media

    Dr Jacques Robert

  62. No association between XRCC3 Thr241Met and XPD Lys751Gln polymorphisms and the risk of colorectal cancer in West Algerian population: a case–control study

    Article • Medical Oncology, April 2014, Springer Science + Business Media

    Dr Jacques Robert

  63. Amphibian IFN responses to the ranavirus FV3

    Article • Journal of Virology, March 2014, ASM Journals

    Dr Jacques Robert

  64. A functionalized heterobimetallic99mTc/Re complex as a potential dual-modality imaging probe: synthesis, photophysical properties, cytotoxicity and cellular imaging investigations

    Article • Dalton Transactions, January 2014, Royal Society of Chemistry

    Dr Jacques Robert

  65. Mechanisms of amphibian macrophage development: characterization of the Xenopus laevis colony-stimulating factor-1 receptor

    Article • The International Journal of Developmental Biology, January 2014, UBC Press

    Dr Jacques Robert

  66. Cytotoxic effect of chlorpyrifos ethyl and its degradation derivatives by Pseudomonas peli strain isolated from the Oued Hamdoun River (Tunisia)

    Article • Toxicology and Industrial Health, November 2013, SAGE Publications

    Dr Jacques Robert

  67. Evaluation of antiproliferative and antioxidant activities of the organic extract and its polar fractions from the Mediterranean gorgonian Eunicella singularis

    Article • Environmental Toxicology and Pharmacology, September 2013, Elsevier

    Dr Jacques Robert

  68. Xenopus Class Ib-restricted iT cells

    Article • Proceedings of the National Academy of Sciences, August 2013, Proceedings of the National Academy of Sciences

    Dr Jacques Robert

  69. Recent Research Progress and Potential Uses of the Amphibian Xenopus as a Biomedical and Immunological Model System

    Article • Resources, July 2013, MDPI AG

    Dr Jacques Robert

  70. Antitumor activity of semisynthetic derivatives of Aconitum alkaloids

    Article • Investigational New Drugs, June 2013, Springer Science + Business Media

    Dr Jacques Robert

  71. Antiproliferative activity and phenolics of the Mediterranean seaweed Laurencia obusta

    Article • Industrial Crops and Products, May 2013, Elsevier

    Dr Jacques Robert

  72. Biologie de la métastase

    Article • Bulletin du Cancer, April 2013, Elsevier

    Dr Jacques Robert

  73. Decolorization does not always mean detoxification: case study of a newly isolated Pseudomonas peli for decolorization of textile wastewater

    Article • Environmental Science and Pollution Research, March 2013, Springer Science + Business Media

    Dr Jacques Robert

  74. Effective RNAi-mediated  2-microglobulin loss of function by transgenesis in Xenopus laevis

    Article • Biology Open, February 2013, The Company of Biologists

    Dr Jacques Robert

  75. Xenopus liver macrophage precursors

    Article • Journal of Innate Immunity, January 2013, Karger Publishers

    Dr Jacques Robert

  76. Short curcumin treatment modulates oxidative stress, arginase activity, aberrant crypt foci, and TGF-β1 and HES-1 transcripts in 1,2-dimethylhydrazine-colon carcinogenesis in mice

    Article • Toxicology, December 2012, Elsevier

    Dr Jacques Robert

  77. R4 regulators of G protein signaling (RGS) identify an ancient MHC-linked synteny group

    Article • Immunogenetics, November 2012, Springer Science + Business Media

    Dr Jacques Robert

  78. Susceptibility of Xenopus laevis tadpoles to infection by the ranavirus Frog-Virus 3 correlates with a reduced and delayed innate immune response in comparison with adult frogs

    Article • Virology, October 2012, Elsevier

    Dr Jacques Robert

  79. Gene Expression Signature Predicting High-Grade Prostate Cancer Responses to Oxaliplatin

    Article • Molecular Pharmacology, September 2012, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Dr Jacques Robert

  80. Hemisynthesis and antiproliferative properties of mono-[O-(14-benzoylaconine-8-yl)]esters and bis-[O-(14-benzoylaconine-8-yl)]esters

    Article • European Journal of Medicinal Chemistry, August 2012, Elsevier

    Dr Jacques Robert

  81. Immune Evasion Strategies of Ranaviruses and Innate Immune Responses to These Emerging Pathogens

    Article • Viruses, June 2012, MDPI AG

    Dr Jacques Robert

  82. Absence of transcriptomic signature of response to chemotherapy in metastatic colorectal carcinoma patients

    Article • Pharmacogenomics, March 2012, Future Medicine

    Dr Jacques Robert

  83. Anti‐Inflammatory and Antiproliferative Activities of Organic Fractions from the Mediterranean Brown Seaweed, Cystoseira Compressa

    Article • Drug Development Research, March 2012, Wiley

    Dr Jacques Robert

  84. Deciphering the role of the ERCC2 gene polymorphism on anticancer drug sensitivity

    Article • Carcinogenesis, February 2012, Oxford University Press (OUP)

    Dr Jacques Robert

  85. “Ranaviruses: An emerging threat to ectothermic vertebrates” Report of the First International Symposium on Ranaviruses, Minneapolis MN July 8, 2011

    Article • Developmental & Comparative Immunology, February 2012, Elsevier

    Dr Jacques Robert

  86. Evaluation of antiproliferative and anti-inflammatory activities of methanol extract and its fractions from the Mediterranean sponge

    Article • Cancer Cell International, January 2012, Springer Science + Business Media

    Dr Jacques Robert

  87. Optimized transgenesis inXenopus laevis/gilliisogenetic clones for immunological studies

    Article • genesis, December 2011, Wiley

    Dr Jacques Robert

  88. Anti-inflammatory, anti-proliferative and anti-oxidant activities of organic extracts from the Mediterranean seaweed, Cystoseira crinita

    Article • AFRICAN JOURNAL OF BIOTECHNOLOGY, November 2011, Academic Journals

    Dr Jacques Robert

  89. Ranavirus: past, present and future

    Article • Proceedings of the Royal Society B Biological Sciences, November 2011, Royal Society Publishing

    Dr David Lesbarreres, Dr Jacques Robert

  90. Médicaments anticancéreux : de la chimiothérapie cytotoxique aux thérapies ciblées

    Article • Bulletin du Cancer, November 2011, Elsevier

    Dr Jacques Robert

  91. Les inhibiteurs de tyrosine kinase

    Article • Bulletin du Cancer, November 2011, Elsevier

    Dr Jacques Robert

  92. Antiviral Immunity in Amphibians

    Article • Viruses, October 2011, MDPI AG

    Dr Jacques Robert

  93. Waterborne infectivity of the Ranavirus frog virus 3 in Xenopus laevis

    Article • Virology, September 2011, Elsevier

    Dr Jacques Robert

  94. The genus Xenopus as a multispecies model for evolutionary and comparative immunobiology of the 21st century

    Article • Developmental & Comparative Immunology, September 2011, Elsevier

    Dr Jacques Robert

  95. Comparative Study of Skin Graft Tolerance and Rejection in the Frog Xenopus Laevis

    Article • August 2011, IntechOpen

    Dr Jacques Robert

  96. Improved Knockout Methodology Reveals That Frog Virus 3 Mutants Lacking either the 18K Immediate-Early Gene or the Truncated vIF-2  Gene Are Defective for Replication and Growth In Vivo

    Article • Journal of Virology, August 2011, ASM Journals

    Dr Jacques Robert

  97. Encapsulation of Docetaxel into PEGylated Gold Nanoparticles for Vectorization to Cancer Cells

    Article • ChemMedChem, August 2011, Wiley

    Dr Jacques Robert

  98. La pollution atmosphérique, cause de cancer bronchique ?

    Article • Archives des Maladies Professionnelles et de l Environnement, June 2011, Elsevier

    Dr Jacques Robert

  99. Ecology of Viruses Infecting Ectothermic Vertebrates-The Impact of Ranavirus Infections on Amphibians

    Article • May 2011, Wiley

    Dr Jacques Robert

  100. ERCC1 and ERCC2 Polymorphisms Predict Clinical Outcomes of Oxaliplatin-Based Chemotherapies in Gastric and Colorectal Cancer: A Systemic Review and Meta-analysis

    Article • Clinical Cancer Research, March 2011, American Association for Cancer Research (AACR)

    Dr Jacques Robert

  101. Phylogenetic and developmental study of CD4, CD8 α and β T cell co-receptor homologs in two amphibian species, Xenopus tropicalis and Xenopus laevis

    Article • Developmental & Comparative Immunology, March 2011, Elsevier

    Dr Jacques Robert

  102. Présentation générale des mécanismes de réparation de l'ADN

    Article • Bulletin du Cancer, March 2011, Elsevier

    Dr Jacques Robert

  103. ERCC5/XPG, ERCC1, and BRCA1 gene status and clinical benefit of trabectedin in patients with soft tissue sarcoma

    Article • Cancer, February 2011, Wiley

    Dr Jacques Robert

  104. Vers une prescription individualisée des traitements anticancéreux

    Article • Journal africain du cancer / African Journal of Cancer, January 2011, Springer Science + Business Media

    Dr Jacques Robert

  105. Remarkable Conservation of Distinct Nonclassical MHC Class I Lineages in Divergent Amphibian Species

    Article • The Journal of Immunology, January 2011, The American Association of Immunologists

    Dr Jacques Robert

  106. Cytochrome P450 1B1 Gene Polymorphisms as Predictors of Anticancer Drug Activity: Studies with In vitro Models

    Article • Molecular Cancer Therapeutics, December 2010, American Association for Cancer Research (AACR)

    Dr Jacques Robert

  107. Signalisation cellulaire et cancer

    Article • Bulletin du Cancer, November 2010, Elsevier

    Dr Jacques Robert

  108. Recommended nomenclature for five mammalian carboxylesterase gene families: human, mouse, and rat genes and proteins

    Article • Mammalian Genome, October 2010, Springer Science + Business Media

    Roger Holmes, Dr Jacques Robert

  109. Comparative in vivo Study of gp96 Adjuvanticity in the Frog Xenopus laevis

    Article • Journal of Visualized Experiments, September 2010, MyJove Corporation

    Dr Jacques Robert

  110. Comparative study of tumorigenesis and tumor immunity in invertebrates and nonmammalian vertebrates

    Article • Developmental & Comparative Immunology, September 2010, Elsevier

    Dr Jacques Robert

  111. Phylogeny, genomic organization and expression of λ and κ immunoglobulin light chain genes in a reptile, Anolis carolinensis

    Article • Developmental & Comparative Immunology, May 2010, Elsevier

    Dr Jacques Robert

  112. The Genome of the Western Clawed Frog Xenopus tropicalis

    Article • Science, April 2010, American Association for the Advancement of Science

    Dr Jacques Robert

  113. Innate Immune Responses and Permissiveness to Ranavirus Infection of Peritoneal Leukocytes in the Frog Xenopus laevis

    Article • Journal of Virology, March 2010, ASM Journals

    Dr Jacques Robert

  114. The amphibians Xenopus laevis and Silurana tropicalis possess a family of activating KIR-related Immunoglobulin-like Receptors

    Article • Developmental & Comparative Immunology, March 2010, Elsevier

    Dr Jacques Robert

  115. Emerging Ranaviral Infectious Diseases and Amphibian Decline

    Article • Diversity, February 2010, MDPI AG

    Dr Jacques Robert

  116. Expression Profiling the Temperature-Dependent Amphibian Response to Infection by Batrachochytrium dendrobatidis

    Article • PLoS ONE, December 2009, PLOS

    Dr Ming-Shi Li, Professor Matthew C Fisher, Dr Jacques Robert

  117. Mass mortality associated with a frog virus 3- like Ranavirus infection in farmed tadpoles Rana catesbeiana from Brazil

    Article • Diseases of Aquatic Organisms, November 2009, Inter-Research Science Center

    Dr Jacques Robert

  118. Control of asthma in children: still unacceptable? A French cross-sectional study

    Article • Respiratory Medicine, September 2009, Elsevier

    Dr Jacques Robert

  119. Involvement of gene polymorphisms of the folate pathway enzymes in gene expression and anticancer drug sensitivity using the NCI-60 panel as a model

    Article • European Journal of Cancer, September 2009, Elsevier

    Dr Jacques Robert

  120. Genome-Wide Transcriptional Response of Silurana (Xenopus) tropicalis to Infection with the Deadly Chytrid Fungus

    Article • PLoS ONE, August 2009, PLOS

    Dr Jacques Robert

  121. ABC Transporters and Multidrug Resistance

    Article • July 2009, Wiley

    Dr Jacques Robert

  122. The association between the T309G polymorphism of the MDM2 gene and sensitivity to anticancer drug is dependent on the p53 mutational status in cellular models

    Article • British Journal of Cancer, June 2009, Springer Science + Business Media

    Dr Jacques Robert

  123. Current knowledge of the immune system of the amphibian Xenopus.

    Article • Developmental Dynamics, June 2009, Wiley

    Dr Jacques Robert

  124. Isolation of a Latimeria menadoensis heat shock protein 70 (Lmhsp70) that has all the features of an inducible gene and encodes a functional molecular chaperone

    Article • Molecular Genetics and Genomics, May 2009, Springer Science + Business Media

    Dr Jacques Robert

  125. Xenopus, a unique comparative model to explore the role of certain heat shock proteins and non-classical MHC class Ib gene products in immune surveillance

    Article • Immunologic Research, February 2009, Springer Science + Business Media

    Dr Jacques Robert

  126. Tumorigenesis and anti-tumor immune responses in Xenopus

    Article • Frontiers in Bioscience, January 2009, IMR Press

    Dr Jacques Robert

  127. In vivo and in vitro techniques for comparative study of antiviral T-cell responses in the amphibian Xenopus

    Article • Biological Procedures Online, December 2008, Springer Science + Business Media

    Dr Jacques Robert

  128. Pharmacokinetic and pharmacogenetic determinants of the activity and toxicity of irinotecan in metastatic colorectal cancer patients

    Article • British Journal of Cancer, September 2008, Springer Science + Business Media

    Dr Jacques Robert

  129. Impact of EGFR Gene Polymorphisms on Anticancer Drug Cytotoxicity In Vitro

    Article • Molecular Diagnosis & Therapy, July 2008, Springer Science + Business Media

    Dr Jacques Robert

  130. A chemotherapy-associated senescence bystander effect in breast cancer cells

    Article • Cancer Biology & Therapy, June 2008, Taylor & Francis

    Dr Jacques Robert

  131. Synthesis and antiproliferative activity of aryl- and heteroaryl-hydrazones derived from xanthone carbaldehydes

    Article • European Journal of Medicinal Chemistry, June 2008, Elsevier

    Dr Jacques Robert

  132. Protein arginine (N)‐methyl transferase 7 (PRMT7) as a potential target for the sensitization of tumor cells to camptothecins

    Article • FEBS Letters, March 2008, Wiley

    Dr Jacques Robert

  133. Phylogenetic Conservation of Glycoprotein 96 Ability to Interact with CD91 and Facilitate Antigen Cross-Presentation

    Article • The Journal of Immunology, March 2008, The American Association of Immunologists

    Dr Jacques Robert

  134. The Xenopus FcR family demonstrates continually high diversification of paired receptors in vertebrate evolution

    Article • BMC Evolutionary Biology, January 2008, Springer Science + Business Media

    Dr Jacques Robert

  135. Determination of ERCC2 Lys751Gln and GSTP1 Ile105Val gene polymorphisms in colorectal cancer patients: relationships with treatment outcome

    Article • Pharmacogenomics, December 2007, Future Medicine

    Dr Jacques Robert

  136. Localization and Differential Expression of Activation-Induced Cytidine Deaminase in the Amphibian Xenopus upon Antigen Stimulation and during Early Development

    Article • The Journal of Immunology, November 2007, The American Association of Immunologists

    Dr Jacques Robert

  137. Les poisons du fuseau

    Article • ONCOLOGIE, November 2007, De Gruyter

    Dr Jacques Robert

  138. XENOPUS LAEVIS: A POSSIBLE VECTOR OF RANAVIRUS INFECTION?

    Article • Journal of Wildlife Diseases, October 2007, Wildlife Disease Association

    Dr Jacques Robert

  139. Conservation of IL‐6 trans‐signaling mechanisms controlling L‐selectin adhesion by fever‐range thermal stress

    Article • European Journal of Immunology, September 2007, Wiley

    Dr Jacques Robert

  140. Involvement of nonclassical MHC class Ib molecules in heat shock protein‐mediated anti‐tumor responses

    Article • European Journal of Immunology, May 2007, Wiley

    Dr Jacques Robert

  141. Functional study of the 830C>G polymorphism of the human carboxylesterase 2 gene

    Article • Cancer Chemotherapy and Pharmacology, May 2007, Springer Science + Business Media

    Dr Jacques Robert

  142. Inhibition of Topoisomerase I Cleavage Activity by Thiol-reactive Compounds

    Article • Journal of Biological Chemistry, May 2007, Elsevier

    Dr Jacques Robert

  143. Long-term and short-term models for studying anthracycline cardiotoxicity and protectors

    Article • Cardiovascular Toxicology, April 2007, Springer Science + Business Media

    Dr Jacques Robert

  144. Involvement of gene polymorphisms of thymidylate synthase in gene expression, protein activity and anticancer drug cytotoxicity using the NCI-60 panel

    Article • European Journal of Cancer, March 2007, Elsevier

    Dr Jacques Robert

  145. Prédiction de la réponse aux anticancéreux par analyse du transcriptome

    Article • Bio Tribune Magazine, March 2007, Springer Science + Business Media

    Dr Jacques Robert

  146. Techniques de recherche des polymorphismes génétiques

    Article • Bio Tribune Magazine, March 2007, Springer Science + Business Media

    Dr Jacques Robert

  147. In Vivo Study of T-Cell Responses to Skin Alloantigens in Xenopus Using a Novel Whole-Mount Immunohistology Method

    Article • Transplantation, January 2007, Wolters Kluwer Health

    Dr Jacques Robert

  148. A phase II study for the evaluation of quinine as a modulator of multidrug resistance in non-Hodgkin’s lymphoma

    Article • European Journal of Cancer, January 2007, Elsevier

    Dr Jacques Robert

  149. Characterization of Primary and Memory CD8 T-Cell Responses against Ranavirus (FV3) in Xenopus laevis

    Article • Journal of Virology, December 2006, ASM Journals

    Dr Jacques Robert

  150. Preclinical assessment of anthracycline cardiotoxicity in laboratory animals: Predictiveness and pitfalls

    Article • Cell Biology and Toxicology, October 2006, Springer Science + Business Media

    Dr Jacques Robert

  151. Identification of gene polymorphisms of human DNA topoisomerase I in the National Cancer Institute panel of human tumour cell lines

    Article • British Journal of Cancer, September 2006, Springer Science + Business Media

    Dr Jacques Robert

  152. Relationships between genetic polymorphisms and anticancer drug cytotoxicity vis-à-vis the NCI-60 panel

    Article • Pharmacogenomics, September 2006, Future Medicine

    Dr Jacques Robert

  153. A phase I study of intravenous liposomal daunorubicin (DaunoXome) in paediatric patients with relapsed or resistant solid tumours

    Article • British Journal of Cancer, August 2006, Springer Science + Business Media

    Dr Jacques Robert

  154. Genetic polymorphisms of the XPG and XPD nucleotide excision repair genes in sarcoma patients

    Article • International Journal of Cancer, July 2006, Wiley

    Dr Jacques Robert

  155. Structural Phylogenetic Analysis of Activation-Induced Deaminase Function

    Article • The Journal of Immunology, July 2006, The American Association of Immunologists

    Dr Jacques Robert

  156. Mitochondrial localization and activity of P-glycoprotein in doxorubicin-resistant K562 cells

    Article • Biochemical Pharmacology, April 2006, Elsevier

    Dr Jacques Robert

  157. Experimental study of dexrazoxane–anthracycline combinations using the model of isolated perfused rat heart

    Article • Toxicology Letters, February 2006, Elsevier

    Dr Jacques Robert

  158. Generation of a long-lasting, protective, and neutralizing antibody response to the ranavirus FV3 by the frog Xenopus

    Article • Developmental & Comparative Immunology, January 2006, Elsevier

    Dr Jacques Robert

  159. 8-O-Azeloyl-14-benzoylaconine: A new alkaloid from the roots of Aconitum karacolicum Rapcs and its antiproliferative activities

    Article • Bioorganic & Medicinal Chemistry, December 2005, Elsevier

    Dr Jacques Robert

  160. Major improvement of the reference method of the French drug resistance network for P-glycoprotein detection in human haematological malignancies

    Article • Leukemia Research, September 2005, Elsevier

    Dr Jacques Robert

  161. Predicting drug response and toxicity based on gene polymorphisms

    Article • Critical Reviews in Oncology/Hematology, June 2005, Elsevier

    Dr Jacques Robert

  162. Pharmacog�n�tique?pharmacog�nomie, quelle est la diff�rence?

    Article • ONCOLOGIE, March 2005, De Gruyter

    Dr Jacques Robert

  163. Pharmacogenetics of MDR family proteins

    Article • ONCOLOGIE, March 2005, De Gruyter

    Dr Jacques Robert

  164. Pharmacog�n�tique de l?irinot�can: la carboxylest�rase 2

    Article • ONCOLOGIE, March 2005, De Gruyter

    Dr Jacques Robert

  165. Prediction of anticancer drug response by transcriptome analysis. The new pathways of pharmacogenomics

    Article • ONCOLOGIE, March 2005, De Gruyter

    Dr Jacques Robert

  166. Techniques de recherche des polymorphismes génétiques

    Article • ONCOLOGIE, March 2005, De Gruyter

    Dr Jacques Robert

  167. Adaptive immunity and histopathology in frog virus 3-infected Xenopus

    Article • Virology, February 2005, Elsevier

    Dr Jacques Robert

  168. CD91 up-regulates upon immune stimulation in Xenopus adult but not larval peritoneal leukocytes

    Article • Immunogenetics, December 2004, Springer Science + Business Media

    Dr Jacques Robert

  169. Pharmacogenetics of human carboxylesterase 2, an enzyme involved in the activation of irinotecan into SN-38

    Article • Clinical Pharmacology & Therapeutics, December 2004, Wiley

    Dr Jacques Robert

  170. Phylogenetic Conservation of gp96-Mediated Antigen-Specific Cellular Immunity: New Evidence from Adoptive Cell Transfer in Xenopus

    Article • Transplantation, November 2004, Wolters Kluwer Health

    Dr Jacques Robert

  171. Predicting drug response based on gene expression

    Article • Critical Reviews in Oncology/Hematology, September 2004, Elsevier

    Dr Jacques Robert

  172. Anti‐tumor MHC class Ia‐unrestricted CD8 T cell cytotoxicity elicited by the heat shock protein gp96

    Article • European Journal of Immunology, August 2004, Wiley

    Dr Jacques Robert

  173. Pharmacogénétique et pharmacogénomique des cancers

    Article • Pathologie Biologie, July 2004, Elsevier

    Dr Jacques Robert

  174. Xenopus as an experimental model for studying evolution of hsp–immune system interactions

    Article • Methods, January 2004, Elsevier

    Dr Jacques Robert

  175. Molecular Determinants of the Cytotoxicity of Platinum Compounds

    Article • Cancer Research, January 2004, American Association for Cancer Research (AACR)

    Dr Jacques Robert

  176. Multidrug Resistance Reversal Agents

    Article • Journal of Medicinal Chemistry, October 2003, American Chemical Society (ACS)

    Dr Jacques Robert

  177. Signaling FcRγ and TCRζ subunit homologs in the amphibian Xenopus laevis

    Article • Developmental & Comparative Immunology, September 2003, Elsevier

    Dr Jacques Robert

  178. Ontogeny of Xenopus NK cells in the absence of MHC class I antigens

    Article • Developmental & Comparative Immunology, September 2003, Elsevier

    Dr Jacques Robert

  179. DNA topoisomerase IIα expression and the response to primary chemotherapy in breast cancer

    Article • British Journal of Cancer, August 2003, Springer Science + Business Media

    Dr Jacques Robert

  180. Development and characterization of a model system to study amphibian immune responses to iridoviruses

    Article • Virology, July 2003, Elsevier

    Dr Jacques Robert

  181. Evolution of heat shock protein and immunity

    Article • Developmental & Comparative Immunology, June 2003, Elsevier

    Dr Jacques Robert

  182. Bacterial stimulation upregulates the surface expression of the stress protein gp96 on B cells in the frog Xenopus

    Article • Cell Stress and Chaperones, January 2003, Springer Science + Business Media

    Dr Jacques Robert

  183. Identification and characterization of Xenopus CD8+ T cells expressing an NK cell-associated molecule

    Article • European Journal of Immunology, June 2002, Wiley

    Dr Jacques Robert

  184. Determination of Drug Interactions Occurring with the Metabolic Pathways of Irinotecan: Figure 1

    Article • Drug Metabolism and Disposition, June 2002, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Dr Jacques Robert

  185. Determinants of the cytotoxicity of irinotecan in two human colorectal tumor cell lines

    Article • Cancer Chemotherapy and Pharmacology, April 2002, Springer Science + Business Media

    Dr Jacques Robert

  186. Effects of paclitaxel, cyclophosphamide, ifosfamide, tamoxifen and cyclosporine on the metabolism of methoxymorpholinodoxorubicin in human liver microsomes

    Article • Cancer Chemotherapy and Pharmacology, April 2002, Springer Science + Business Media

    Dr Jacques Robert

  187. Alterations in the expression of cytochrome c oxidase subunits in doxorubicin-resistant leukemia K562 cells

    Article • Biochemical Pharmacology, March 2002, Elsevier

    Dr Jacques Robert

  188. Minor Histocompatibility Antigen-Specific MHC-Restricted CD8 T Cell Responses Elicited by Heat Shock Proteins

    Article • The Journal of Immunology, February 2002, The American Association of Immunologists

    Dr Jacques Robert

  189. MHC-RESTRICTED AND -UNRESTRICTED CD8 T CELLS

    Article • Transplantation, December 2001, Wolters Kluwer Health

    Dr Jacques Robert

  190. Metabolism of methoxymorpholino‐doxorubicin in rat, dog and monkey liver microsomes: comparison with human microsomes

    Article • Fundamental and Clinical Pharmacology, December 2001, Wiley

    Dr Jacques Robert

  191. Effects of the combination of camptothecin and doxorubicin or etoposide on rat glioma cells and camptothecin-resistant variants

    Article • British Journal of Cancer, September 2001, Springer Science + Business Media

    Dr Jacques Robert

  192. Resistance to cytotoxic agents

    Article • Current Opinion in Pharmacology, August 2001, Elsevier

    Dr Jacques Robert

  193. Hepatic extraction, metabolism, and biliary excretion of irinotecan in the isolated perfused rat liver

    Article • Journal of Pharmaceutical Sciences, June 2001, Elsevier

    Dr Jacques Robert

  194. Separation and determination of liposomal and non-liposomal daunorubicin from the plasma of patients treated with Daunoxome

    Article • Journal of Chromatography B Biomedical Sciences and Applications, June 2001, Elsevier

    Dr Jacques Robert

  195. In vitro thymocyte differentiation in MHC class I-negative Xenopus larvae

    Article • Developmental & Comparative Immunology, May 2001, Elsevier

    Dr Jacques Robert

  196. Sequential gene expression of P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP) and lung resistance protein: functional activity of P-gp and MRP present in the doxorubicin-resistant human K562 cell lines

    Article • Anti-Cancer Drugs, March 2001, Wolters Kluwer Health

    Dr Jacques Robert

  197. Down-regulation of bcr-abl and bcl-xL expression in a leukemia cell line and its doxorubicin-resistant variant by topoisomerase II inhibitors

    Article • Biochemical Pharmacology, December 2000, Elsevier

    Dr Jacques Robert

  198. Pharmacokinetics of liposomal daunorubicin (DaunoXome) during a phase I-II study in children with relapsed acute lymphoblastic leukaemia

    Article • Cancer Chemotherapy and Pharmacology, November 2000, Springer Science + Business Media

    Dr Jacques Robert

  199. B-cell development in the amphibianXenopus

    Article • Immunological Reviews, June 2000, Wiley

    Dr Jacques Robert

  200. B-cell development in the amphibian Xenopus

    Article • Immunological Reviews, June 2000, Wiley

    Dr Jacques Robert

  201. New targets, new drugs

    Article • Critical Reviews in Oncology/Hematology, May 2000, Elsevier

    Dr Jacques Robert

  202. Preclinical Evaluation of the Cardiotoxicity of Taxane–Anthracycline Combinations Using the Model of Isolated Perfused Rat Heart

    Article • Toxicology and Applied Pharmacology, March 2000, Elsevier

    Dr Jacques Robert

  203. Clinical pharmacokinetics of the irinotecan metabolite 4-piperidinopiperidine and its possible clinical importance

    Article • Cancer Chemotherapy and Pharmacology, January 2000, Springer Science + Business Media

    Dr Jacques Robert

  204. A phase II trial of induction and consolidation therapy of acute myeloid leukemia with weekly oral idarubicin alone in poor risk elderly patients

    Article • Leukemia, October 1999, Springer Science + Business Media

    Dr Jacques Robert

  205. Preclinical evaluation of the cardiac toxicity of HMR-1826, a novel prodrug of doxorubicin

    Article • British Journal of Cancer, August 1999, Springer Science + Business Media

    Dr Jacques Robert

  206. Comparative cardiotoxicity of idarubicin and doxorubicin using the isolated perfused rat heart model

    Article • Anti-Cancer Drugs, August 1999, Wolters Kluwer Health

    Dr Jacques Robert

  207. Multidrug resistance in oncology: diagnostic and therapeutic approaches

    Article • European Journal of Clinical Investigation, June 1999, Wiley

    Dr Jacques Robert

  208. In vitro differentiation of a CD4/CD8 double-positive equivalent thymocyte subset in adult Xenopus

    Article • International Immunology, April 1999, Oxford University Press (OUP)

    Dr Jacques Robert

  209. Ontogeny of CTX expression in xenopus

    Article • Developmental & Comparative Immunology, December 1998, Elsevier

    Dr Jacques Robert

  210. Evolution of immune surveillance and tumor immunity: studies in Xenopus

    Article • Immunological Reviews, December 1998, Wiley

    Dr Jacques Robert

  211. Resistance to Anticancer Drugs: Are We Ready to Use Biologic Information for the Treatment of Patients With Cancer?

    Article • Therapeutic Drug Monitoring, October 1998, Wolters Kluwer Health

    Dr Jacques Robert

  212. Benefits of pharmacological knowledge in the design and monitoring of cancer chemotherapy

    Article • Pathology & Oncology Research, September 1998, Springer Science + Business Media

    Dr Jacques Robert

  213. Approaches to multidrug resistance reversal

    Article • Expert Opinion on Investigational Drugs, June 1998, Informa Healthcare

    Dr Jacques Robert

  214. Doxorubicin-Induced Alterations of c-myc and c-jun Gene Expression in Rat Glioblastoma Cells: Role of c-jun in Drug Resistance and Cell Death

    Article • Biochemical Pharmacology, June 1998, Elsevier

    Dr Jacques Robert

  215. Long-term weekly treatment of colorectal metastatic cancer with fluorouracil and leucovorin: results of a multicentric prospective trial of fluorouracil dosage optimization by pharmacokinetic monitoring in 152 patients.

    Article • Journal of Clinical Oncology, April 1998, American Society of Clinical Oncology (ASCO)

    Dr Jacques Robert

  216. Determination of unbound platinum after oxaliplatin administration

    Article • Anti-Cancer Drugs, March 1998, Wolters Kluwer Health

    Dr Jacques Robert

  217. Transcriptional down-regulation of c-myc expression in an erythroleukemic cell line, K562, and its doxorubicin-resistant variant by two topoisomerase II inhibitors, doxorubicin and amsacrine

    Article • Anti-Cancer Drugs, March 1998, Wolters Kluwer Health

    Dr Jacques Robert

  218. Genealogical study of oculopharyngeal muscular dystrophy in France

    Article • Neuromuscular Disorders, October 1997, Elsevier

    Dr Jacques Robert

  219. Antibody Cross-Linking of the Thymocyte-Specific Cell Surface Molecule CTX Causes Abnormal Mitosis and Multinucleation of Tumor Cells

    Article • Experimental Cell Research, August 1997, Elsevier

    Dr Jacques Robert

  220. The transformation of irinotecan (CPT-11) to its active metabolite SN-38 by human liver microsomes Differential hydrolysis for the lactone and carboxylate forms

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, July 1997, Springer Science + Business Media

    Dr Jacques Robert

  221. Cellular pharmacology of lipophilic anthracyclines in human tumor cells in culture selected for resistance to doxorubicin

    Article • Anti-Cancer Drugs, July 1997, Wolters Kluwer Health

    Dr Jacques Robert

  222. Confocal microscopy of idarubicin localisation

    Article • British Journal of Cancer, July 1997, Springer Science + Business Media

    Dr Jacques Robert

  223. French multicentric evaluation of mdr1 gene expression by RT-PCR in leukemia and solid tumours. Standardization of RT-PCR and preliminary comparisons between RT-PCR and immunohistochemistry in solid tumours

    Article • Leukemia, July 1997, Springer Science + Business Media

    Dr Jacques Robert

  224. Multicentric evaluation of the MDR phenotype in leukemia

    Article • Leukemia, July 1997, Springer Science + Business Media

    Dr Jacques Robert

  225. Differential Stabilization of Topoisomerase‐II–DNA Cleavable Complexes by Doxorubicin and Etoposide in Doxorubicin‐Resistant Rat Glioblastoma Cells

    Article • European Journal of Biochemistry, April 1997, Wiley

    Dr Jacques Robert

  226. Cross-linking CTX, a novel thymocyte-specific molecule, inhibits the growth of lymphoid tumor cells in xenopus

    Article • Molecular Immunology, February 1997, Elsevier

    Dr Jacques Robert

  227. Glucuronidation of SN‐38, the Active Metabolite of Irinotecan, by Human Hepatic Microsomes

    Article • Pharmacology & Toxicology, February 1997, Wiley

    Dr Jacques Robert

  228. Relationship between the inhibition of azidopine binding to P-glycoprotein by MDR modulators and their efficiency in restoring doxorubicin intracellular accumulation

    Article • Cancer Letters, December 1996, Elsevier

    Dr Jacques Robert

  229. Conversion of irinotecan (CPT-11) to its active metabolite, 7-ethyl-10-hydroxycamptothecin (SN-38), by Human Liver Carboxylesterase

    Article • Biochemical Pharmacology, October 1996, Elsevier

    Dr Jacques Robert

  230. Effects of modulators of multidrug resistance on the expression of the MDR1 gene in human KB cells in culture

    Article • Anti-Cancer Drugs, September 1996, Wolters Kluwer Health

    Professor François DOIGNON, Dr Jacques Robert

  231. Semisynthesis of RPR 121056A, a major metabolite of irinotecan (CPT-11)

    Article • Tetrahedron Letters, August 1996, Elsevier

    Dr Jacques Robert

  232. CTX, a novel molecule specifically expressed on the surface of cortical thymocytes inXenopus

    Article • European Journal of Immunology, April 1996, Wiley

    Dr Jose A. Garcia-Sanz, Dr Jacques Robert

  233. Development of the model of rat isolated perfused heart for the evaluation of anthracycline cardiotoxicity and its circumvention

    Article • British Journal of Pharmacology, April 1996, Wiley

    Dr Jacques Robert

  234. On the mechanism of action of doxorubicin encapsulation in nanospheres for the reversal of multidrug resistance

    Article • Cancer Chemotherapy and Pharmacology, March 1996, Springer Science + Business Media

    Dr Jacques Robert

  235. Xenopus lymphoid tumor cell lines

    Article • January 1996, Elsevier

    Dr Jacques Robert

  236. Xenopus lymphoid tumor cell lines

    Article • January 1996, Elsevier

    Dr Jacques Robert

  237. Ontogeny of the alloimmune response against a transplanted tumor in Xenopus laevis

    Article • Differentiation, October 1995, Elsevier

    Dr Jacques Robert

  238. Differential effects of verapamil and quinine on the reversal of doxorubicin resistance in a human leukemia cell line

    Article • International Journal of Cancer, July 1995, Wiley

    Dr Jacques Robert

  239. A Xenopus lymphoid tumor cell line with complete Ig genes rearrangements and T-cell characteristics

    Article • Molecular Immunology, June 1995, Elsevier

    Dr Jacques Robert

  240. Cyclosporin A, verapamil and S9788 reverse doxorubicin resistance in a human medullary thyroid carcinoma cell line

    Article • Anti-Cancer Drugs, February 1995, Wolters Kluwer Health

    Dr Jacques Robert

  241. Direct evaluation of intracellular accumulation of free and polymer-bound anthracyclines

    Article • Cancer Chemotherapy and Pharmacology, January 1995, Springer Science + Business Media

    Dr Irina Zh Shubina, Dr Jacques Robert

  242. Evaluation of anthracycline cardiotoxicity with the model of isolated, perfused rat heart: comparison of new analogues versus doxorubicin

    Article • Cancer Chemotherapy and Pharmacology, January 1995, Springer Science + Business Media

    Dr Jacques Robert

  243. Failure of liposomal encapsulation of doxorubicin to circumvent multidrug resistance in an in vitro model of rat glioblastoma cells

    Article • European Journal of Cancer, January 1995, Elsevier

    Dr Jacques Robert

  244. Identification and kinetics of a ?-glucuronide metabolite of SN-38 in human plasma after administration of the camptothecin derivative irinotecan

    Article • Cancer Chemotherapy and Pharmacology, January 1995, Springer Science + Business Media

    Dr Jacques Robert

  245. Molecular, cellular, and clinical aspects of the pharmacology of 20(S)camptothecin and its derivatives

    Article • Pharmacology & Therapeutics, January 1995, Elsevier

    Dr Jacques Robert

  246. Pharmacological Properties of Oral Idarubicin

    Article • Clinical Drug Investigation, January 1995, Springer Science + Business Media

    Dr Jacques Robert

  247. Reversed-phase high-performance liquid chromatographic method for the simultaneous quantitation of the carboxylate and lactone forms of the camptothecin derivative irinotecan, CPT-11, and its metabolite SN-38 in plasma

    Article • Journal of Chromatography B Biomedical Sciences and Applications, November 1994, Elsevier

    Dr Jacques Robert

  248. Intracellural accretion of free and nanosphere-encapsulated doxorubicin

    Article • Bulletin of Experimental Biology and Medicine, October 1994, Springer Science + Business Media

    Dr Irina Zh Shubina, Dr Jacques Robert

  249. Clinical Pharmacokinetics of Epirubicin

    Article • Clinical Pharmacokinetics, June 1994, Springer Science + Business Media

    Dr Jacques Robert

  250. Multidrug resistance circumvention by a new triazinoaminopiperidine derivative S9788 in vitro: definition of the optimal schedule and comparison with verapamil

    Article • British Journal of Cancer, May 1994, Springer Science + Business Media

    Dr Jacques Robert

  251. Lymphoid Tumors ofXenopus laeviswith Different Capacities for Growth in Larvae and Adults

    Article • Developmental Immunology, January 1994, Hindawi Publishing Corporation

    Dr Jacques Robert

  252. Individual dose adaptation of anticancer drugs

    Article • European Journal of Cancer, January 1994, Elsevier

    Dr Jacques Robert

  253. Modulation of anthracycline accumulation and metabolism in rat hepatocytes in culture by three revertants of multidrug resistance

    Article • Cancer Chemotherapy and Pharmacology, January 1994, Springer Science + Business Media

    Dr Jacques Robert

  254. Expression of MDR1/P glycoprotein in human sarcomas

    Article • British Journal of Cancer, December 1993, Springer Science + Business Media

    Dr Jacques Robert

  255. Differential over‐expression of mdr1 genes in multidrug‐resistant rat glioblastoma cell lines selected with doxorubicin or vincristine

    Article • International Journal of Cancer, August 1993, Wiley

    Dr Jacques Robert

  256. Doxorubicin‐induced oxygen free radical formation in sensitive and doxorubicin‐ resistant variants of rat glioblastoma cell lines

    Article • FEBS Letters, July 1993, Wiley

    Dr Jacques Robert

  257. Doxorubicin‐induced oxygen free radical formation in sensitive and doxorubicin‐resistant variants of rat glioblastoma cell lines

    Article • FEBS Letters, July 1993, Wiley

    Dr Jacques Robert

  258. Pharmacological and molecular characterization of intrinsic and acquired doxorubicin resistance in murine tumor cell lines

    Article • Journal of Cancer Research and Clinical Oncology, July 1993, Springer Science + Business Media

    Dr Jacques Robert

  259. Doxorubicin‐induced oxygen free radical formation in sensitive and doxorubicin‐resistant variants of rat glioblastoma cell lines

    Article • FEBS Letters, May 1993, Wiley

    Dr Jacques Robert

  260. Aspects of the cellular pharmacology of N-l-leucyldoxorubicin in human tumor cell lines

    Article • Biochemical Pharmacology, May 1993, Elsevier

    Dr Jacques Robert

  261. Clinical Pharmacokinetics of Idarubicin

    Article • Clinical Pharmacokinetics, April 1993, Springer Science + Business Media

    Dr Jacques Robert

  262. Diffusion of a particular 4.1(−) hereditary elliptocytosis allele in the French northern Alps

    Article • Journal of Biosocial Science, April 1993, Cambridge University Press

    Dr Jacques Robert

  263. Expression of P-glycoprotein and anionic glutathione S-transferase genes in non-hodgkin's lymphoma

    Article • Leukemia Research, February 1993, Elsevier

    Dr Jacques Robert

  264. Doxorubicin‐induced lipid peroxidation and glutathione peroxidase activity in tumor cell lines selected for resistance to doxorubicin

    Article • European Journal of Biochemistry, January 1993, Wiley

    Dr Jacques Robert

  265. Epirubicin

    Article • Drugs, January 1993, Springer Science + Business Media

    Dr Jacques Robert

  266. New drug design and development in cancer: present status and future perspectives

    Article • Cancer Chemotherapy and Pharmacology, January 1993, Springer Science + Business Media

    Dr Jacques Robert

  267. Reversal of multidrug resistance by a new lipophilic cationic molecule, S9788. Comparison with 11 other MDR-modulating agents in a model of doxorubicin-resistant rat glioblastoma cells

    Article • European Journal of Cancer, January 1993, Elsevier

    Dr Jacques Robert

  268. Use of pharmacokinetic-pharmacodynamic relationships in the development of new anthracyclines

    Article • Cancer Chemotherapy and Pharmacology, January 1993, Springer Science + Business Media

    Dr Jacques Robert

  269. Pharmacokinetics and metabolism of 4'-iodo-4'-deoxy-doxorubicin in humans.

    Article • Journal of Clinical Oncology, July 1992, American Society of Clinical Oncology (ASCO)

    Dr Jacques Robert

  270. P-glycoprotein overexpression cannot explain the complete doxorubicin-resistance phenotype in rat glioblastoma cell lines

    Article • British Journal of Cancer, April 1992, Springer Science + Business Media

    Dr Jacques Robert

  271. Comparative pharmacokinetic study of idarubicin and daunorubicin in leukemia patients

    Article • Hematological Oncology, March 1992, Wiley

    Dr Jacques Robert

  272. Human pharmacokinetics of N-L-leucyl-doxorubicin, a new anthracycline derivative, and its correlation with clinical toxicities

    Article • Clinical Pharmacology & Therapeutics, March 1992, Wiley

    Dr Jacques Robert

  273. Measurement of doxorubicin-induced lipid peroxidation under the conditions that determine cytotoxicity in cultured tumor cells

    Article • Analytical Biochemistry, March 1992, Elsevier

    Dr Jacques Robert

  274. Drug resistance in oncology: from concepts to applications

    Article • Journal of Cancer Research and Clinical Oncology, February 1992, Springer Science + Business Media

    Dr Jacques Robert

  275. In Vitro Growth of Thymic Tumor Cell Lines from Xenopus

    Article • Developmental Immunology, January 1992, Hindawi Publishing Corporation

    Dr Jacques Robert

  276. An abnormal concentration of cases of Rendu-Osler disease in the Valserine valley of the French Jura: a genealogical and demographic study

    Article • Annals of Human Biology, January 1992, Taylor & Francis

    Dr Jacques Robert

  277. Variability in the pharmacokinetics of epirubicin: a population analysis

    Article • Cancer Chemotherapy and Pharmacology, January 1992, Springer Science + Business Media

    Dr Jacques Robert

  278. A Xenopus laevis creatine kinase isozyme (CK-III/III) expressed preferentially in larval striated muscle: cDNA sequence, developmental expression and subcellular immunolocalization

    Article • Genetics Research, August 1991, Cambridge University Press

    Dr Jacques Robert

  279. Limited sampling models for doxorubicin pharmacokinetics.

    Article • Journal of Clinical Oncology, May 1991, American Society of Clinical Oncology (ASCO)

    Dr Jacques Robert

  280. Differential expression of creatine kinase isozymes during development of Xenopus laevis: An unusual heterodimeric isozyme appears at metamorphosis

    Article • Differentiation, February 1991, Elsevier

    Dr Jacques Robert

  281. A pharmacokinetic and pharmacodynamic study of the new anthracycline pirarubicin in breast cancer patients

    Article • Cancer Chemotherapy and Pharmacology, January 1991, Springer Science + Business Media

    Dr Jacques Robert

  282. Shifts in interleukin-4 and interferon-γ production by T cells of patients with elevated serum IgE levels and the modulatory effects of these lymphokines on spontaneous IgE synthesis

    Article • Journal of Allergy and Clinical Immunology, January 1991, Elsevier

    Dr Jacques Robert

  283. Fraser syndrome with renal agenesis in two consanguineous Turkish families

    Article • American Journal of Medical Genetics, August 1990, Wiley

    Dr Jacques Robert

  284. Influence of trimetazidine on deleterious effect of oxygen radical species in post-ischemic acute renal failure in the rat

    Article • Cardiovascular Drugs and Therapy, August 1990, Springer Science + Business Media

    Dr Jacques Robert

  285. Cellular pharmacology of 4'-iodo-4'-deoxydoxorubicin

    Article • British Journal of Cancer, April 1990, Springer Science + Business Media

    Dr Jacques Robert

  286. Development of Mechanisms of Protection Against Oxidative Stress in Doxorubicin-Resistant Rat Tumoral Cells in Culture

    Article • Free Radical Research Communications, January 1990, Taylor & Francis

    Dr Jacques Robert

  287. Metabolism of epirubicin to glucuronides: relationship to the pharmacodynamics of the drug

    Article • Cancer Chemotherapy and Pharmacology, January 1990, Springer Science + Business Media

    Dr Jacques Robert

  288. Comparative activity of anthracycline 13-dihydrometabolites against rat glioblastoma cells in culture

    Article • Biochemical Pharmacology, November 1989, Elsevier

    Dr Jacques Robert

  289. Assessment of the experimental model of transplanted C6 glioblastoma in wistar rats

    Article • Journal of Neuro-Oncology, September 1989, Springer Science + Business Media

    PhD Patricia Vrignaud, Dr Jacques Robert

  290. Age‐related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population

    Article • American Journal of Medical Genetics, March 1989, Wiley

    Dr Jacques Robert

  291. Clinical and pharmacokinetic study of 96-h infusions of doxorubicin in advanced cancer patients

    Article • European Journal of Cancer and Clinical Oncology, March 1989, Elsevier

    Dr Jacques Robert

  292. DUCHENNE MUSCULAR DYSTROPHY: NEONATAL SCREENING AND PRENATAL DIAGNOSIS

    Article • The Lancet, March 1989, Elsevier

    Dr Jacques Robert

  293. Comparative cytotoxicity, DNA synthesis inhibition and drug incorporation of eight anthracyclines in a model of doxorubicin-sensitive and -resistant rat glioblastoma cells

    Article • Biochemical Pharmacology, January 1989, Elsevier

    Dr Jacques Robert

  294. Alteration of ganglioside composition and metabolism in doxorubicin-resistant rat tumoral cells

    Article • Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, December 1988, Elsevier

    PhD Patricia Vrignaud, Dr Jacques Robert

  295. Different cytotoxicity and metabolism of doxorubicin, daunorubicin, epirubicin, esorubicin and idarubicin in cultured human and rat hepatocytes

    Article • Biochemical Pharmacology, October 1988, Elsevier

    Dr Jacques Robert

  296. Purification and characterization of cytoplasmic creatine kinase isozymes ofXenopus laevis

    Article • Biochemical Genetics, October 1988, Springer Science + Business Media

    Dr Jacques Robert

  297. Pharmacokinetics and metabolism of pirarubicin in advanced cancer patients

    Article • European Journal of Cancer and Clinical Oncology, August 1988, Elsevier

    Dr Jacques Robert

  298. The reversal of doxorubicin resistance by verapamil is not due to an effect on calcium channels

    Article • International Journal of Cancer, February 1988, Wiley

    Dr Jacques Robert

  299. Purification and characterization of a casein-kinase-II-type enzyme from Xenopus laevis ovary. Biological effects on the meiotic cell division of full-grown oocyte

    Article • European Journal of Biochemistry, January 1988, Wiley

    Dr Jacques Robert

  300. Free fatty acid uptake is increased in doxorubicin-resistant glioblastoma cells

    Article • Biochimica et Biophysica Acta (BBA) - Biomembranes, August 1987, Elsevier

    PhD Patricia Vrignaud, Dr Jacques Robert

  301. Hepatic extraction, metabolism and biliary excretion of doxorubicin in the isolated prefused rat liver

    Article • Cancer Chemotherapy and Pharmacology, May 1987, Springer Science + Business Media

    PhD Patricia Vrignaud, Dr Jacques Robert

  302. Pharmacokinetics of doxorubicin in sarcoma patients

    Article • European Journal of Clinical Pharmacology, January 1987, Springer Science + Business Media

    PhD Patricia Vrignaud, Dr Jacques Robert

  303. Continuous Infusion or Intravenous Bolus: What Is the Rationale for Doxorubicin Administration?

    Article • Cancer Drug Delivery, January 1987, Mary Ann Liebert Inc

    Dr Jacques Robert

  304. Pharmacokinetics of idarubicin after daily intravenous administration in leukemic patients

    Article • Leukemia Research, January 1987, Elsevier

    Dr Jacques Robert

  305. Metabolism of doxorubicin and epirubicin in adult human hepatocytes in culture

    Article • Pharmacological Research Communications, April 1986, Elsevier

    PhD Patricia Vrignaud, Dr Jacques Robert

  306. Hepatic metabolism of doxorubicin in mice and rats

    Article • European Journal of Drug Metabolism and Pharmacokinetics, April 1986, Springer Science + Business Media

    PhD Patricia Vrignaud, Dr Jacques Robert

  307. Fluorescence anisotropy of kidney lipids and membranes of a hibernating mammal

    Article • Cryobiology, April 1986, Elsevier

    Dr Jacques Robert

  308. Cellular Pharmacology of Doxorubicin in Sensitive and Resistant Rat Glioblastoma Cells in Culture

    Article • Oncology, January 1986, Karger Publishers

    PhD Patricia Vrignaud, Dr Jacques Robert

  309. Evaluation of Drug Therapy and Teratogenic Risk in a Rhone-Alpes District Population of Pregnant Epileptic Women

    Article • European Neurology, January 1986, Karger Publishers

    Dr Jacques Robert

  310. Tentative dose-monitoring of doxorubicin in lymphoma patients

    Article • Medical Oncology and Tumor Pharmacotherapy, December 1985, Springer Science + Business Media

    Dr Jacques Robert

  311. Pharmacokinetics and metabolism of epirubicin during repetitive courses of administration in Hodgkin's patients

    Article • European Journal of Cancer and Clinical Oncology, November 1985, Elsevier

    PhD Patricia Vrignaud, Dr Jacques Robert

  312. Incorporation and turnover of phospholipid precursors in normal and tumoral glial cells in culture

    Article • International Journal of Biochemistry, January 1985, Elsevier

    Dr Jacques Robert

  313. Fluorescence polarization study of lipids and membranes prepared from brain hemispheres of a hibernating mammal

    Article • Biochemical and Biophysical Research Communications, February 1984, Elsevier

    Dr Jacques Robert

  314. Cellular Pharmacokinetics of Doxorubicin in Cultured Mouse Sarcoma Cells Originating from Autochthonous Tumors

    Article • Oncology, January 1984, Karger Publishers

    PhD Patricia Vrignaud, Dr Jacques Robert

  315. Incorporation and metabolism of exogenous fatty acids by cultured normal and tumoral glial cells

    Article • Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, August 1983, Elsevier

    Dr Jacques Robert

  316. Early-phase pharmacokinetics of doxorubicin in non-hodgkin lymphoma patients

    Article • Cancer Chemotherapy and Pharmacology, February 1983, Springer Science + Business Media

    PhD Patricia Vrignaud, Dr Jacques Robert

  317. Metabolism of daunorubicin in sensitive and resistant Ehrlich ascites tumor cells

    Article • Cancer Chemotherapy and Pharmacology, September 1982, Springer Science + Business Media

    Dr Jacques Robert

  318. Pharmacokinetics of adriamycin in patients with breast cancer: Correlation between pharmacokinetic parameters and clinical short-term response

    Article • European Journal of Cancer and Clinical Oncology, August 1982, Elsevier

    Dr Jacques Robert

  319. Changes in lipid composition of the brain cellular membranes of an hibernating mammal during its circannual rhythm

    Article • Comparative Biochemistry and Physiology Part B Comparative Biochemistry, January 1982, Elsevier

    Dr Jacques Robert

  320. Rectocolic familial polyposis; a study of 32 cases

    Article • World Journal of Surgery, July 1981, Wiley

    Dr Jacques Robert

  321. Sanfilippo A syndrome (Mucopolysaccharidosis III A): a neurochemical study

    Article • The Italian Journal of Neurological Sciences, June 1981, Springer Science + Business Media

    Dr Jacques Robert

  322. Phospholipid acyl group composition in normal and tumoral nerve cells in culture

    Article • Lipids, May 1981, Wiley

    Dr Jacques Robert

  323. Uptake of l‐Glutamate and Taurine in Neuroblastoma Cells with Altered Fatty Acid Composition of Membrane Phospholipids

    Article • Journal of Neurochemistry, June 1980, Wiley

    Dr Jacques Robert

  324. Dynamics of Phospholipids in Cultured Cells of Neural Origin

    Article • Biochemical Society Transactions, April 1979, Portland Press Ltd.

    Dr Jacques Robert

  325. SYSTEMATIC NEONATAL SCREENING FOR DUCHENNE MUSCULAR DYSTROPHY

    Article • The Lancet, November 1978, Elsevier

    Dr Jacques Robert

  326. UTILIZATION OF POLYUNSATURATED FATTY ACID SUPPLEMENTS BY CULTURED NEUROBLASTOMA CELLS1

    Article • Journal of Neurochemistry, March 1978, Wiley

    Dr Jacques Robert

  327. Confirmation of the assignment of the human <i>SOD<sub>S</sub> </i>gene to chromosome 21q22

    Article • Cytogenetic and Genome Research, January 1978, Karger Publishers

    Dr Jacques Robert

  328. Polar head groups manipulation of phospholipids in cultured neuroblastoma cells

    Article • Life Sciences, January 1978, Elsevier

    Dr Jacques Robert

  329. Gangliosides of Active and Inactive Neuroblastoma Clones

    Article • Differentiation, August 1977, Elsevier

    Dr Jacques Robert

  330. Thin-layer chromatography of gangliosides

    Article • Journal of Chromatography A, July 1977, Elsevier

    Dr Jacques Robert

  331. Essential fatty acid metabolism in cultured astroblasts

    Article • Biochimie, June 1977, Elsevier

    Dr Jacques Robert

  332. IS VARICELLA VIRUS TERATOGENIC?

    Article • The Lancet, February 1977, Elsevier

    Dr Jacques Robert

  333. NEUTRAL LIPIDS AND PHOSPHOLIPIDS FROM CULTURED ASTROBLASTS

    Article • Journal of Neurochemistry, April 1976, Wiley

    Dr Jacques Robert

  334. Changes in Sugar Composition of Membrane-Bound Glycoproteins during Postnatal Development of Rat Cerebellum

    Article • Biochemical Society Transactions, October 1975, Portland Press Ltd.

    Dr Jacques Robert

  335. Changes of Ganglioside Pattern during Postnatal Development of Rat Cerebellum

    Article • Biochemical Society Transactions, October 1975, Portland Press Ltd.

    Dr Jacques Robert

  336. Quantitation of neutral glycolipids by thin-layer chromatography on precoated plates

    Article • Journal of Chromatography A, July 1975, Elsevier

    Dr Jacques Robert

  337. Gangliosides of glial cells: A comparative study of normal astroblasts in tissue culture and glial cells isolated on sucrose‐ficoll gradients

    Article • FEBS Letters, February 1975, Wiley

    Dr Jacques Robert

  338. Pericentric inversion, inv(10), in a mother and aneusomy by recombination, inv(10),rec(10), in her son

    Article • Cytogenetic and Genome Research, January 1973, Karger Publishers

    Dr Jacques Robert